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Intimal sarcoma of the pulmonary artery is a rare malignant tumor that may be misdiagnosed as chronic pulmonary
thromboembolism, even if various imaging techniques are used. We report a case of a 58-year-old man with
pulmonary artery intimal sarcoma.18F-fleuorodeoxyglucose (FDG) uptake was poor in the mass of the pulmonary
artery, and no other hypermetabolic lesions were noted elsewhere. Our presumptive diagnosis was a massive mural
thrombus and a concomitant chronic thromboembolism. Intravenous heparin and recombinant human tissue-type
plasminogen activator was subsequently administered. However, the patient needed an emergency operation for
sudden aggravation of the vital signs, and the tissue diagnosis was intimal sarcoma with poor clinical outcomes.
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Intimal sarcoma is a rare mesenchymal tumor, and it can
arise from the great arteries. The incidence of pulmonary
artery intimal sarcoma is almost twice that of the aorta
[1]. It usually arises from the intimal layer of the right, left,
and main pulmonary arteries. The usual features of these
tumors are endoluminal growth and later vessel obstruc-
tion or seeding of distal emboli. In addition, in rare cases,
it may extend in a retrograde fashion to the pulmonary
valve and the right ventricle [1,2].
This tumor is highly malignant and the prognosis is
very poor. Survival is usually 12 to 18 months after the
onset of the symptoms [1]. This disease mainly occurs in
adults with female sex predominance, with the mean age
at diagnosis being 48 years [3]. The diagnosis is often de-
layed and difficult, due to gradually developing symp-
toms of the pulmonary artery obstruction and right
heart failure with a long asymptomatic course.Case presentation
A 58-year-old man was admitted with a month’s history
of exertional dyspnea, which had been worsening for* Correspondence: tejung@med.yu.ac.kr
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reproduction in any medium, provided the ortwenty days. The patient was being medicated for dia-
betes mellitus and hypertension. He was relatively stable,
at New York Heart Association functional class II-III.
On physical examination, the patient exhibited tachyp-
nea, with 20 breaths per minute and his oxygen satur-
ation was 92%, his pulse was regular at 95 beats per
minute, and his blood pressure was 130/80 mmHg. Aus-
cultation revealed a prominent second heart sound and
grade 3/6 systolic murmur over the pulmonary area. A
blood count revealed platelets at 57,000/mm3, but the
rest of the work-up revealed no hematologic evidence of
intrinsic hypercoagulability. The N-terminal pro-B-type
natriuretic peptide level was 395 pg/ml (normal range:
0–125) and D-dimer was 0.816 μg/ml (normal range:
0–0.5). The chest radiograph revealed atherosclerotic
cardiovascular change and mild cardiomegaly. Electro-
cardiography showed a sinus rhythm.
Evaluation with transthoracic echocardiography dem-
onstrated a left ventricular ejection fraction of 56%. The
right ventricle was enlarged and severely hypokinetic
with a mobile echogenic mass in the supravalvular area
of the main pulmonary artery. The color Doppler re-
vealed a moderate tricuspid regurgitation. The systolic
pulmonary arterial pressure was estimated with 70 -
mmHg. Subsequent evaluation with contrast-enhanced
computed tomography (CT) of the chest demonstrated a. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chest computed tomography reveals multiple large masses in the main pulmonary artery and both branches. Main pulmonary
artery and left pulmonary artery were almost completely blocked, and the right pulmonary trunk was completely blocked.
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which extended to near total occlusion of the left and
right pulmonary artery, separately (Figure 1). There had
been no intraluminal mass of the pulmonary artery on a
chest CT 8 years earlier. Cardiac magnetic resonance
imaging confirmed the mass beginning near the pulmonic
valve, centered in the main pulmonary artery and
extending into the right ventricular outflow tract, and onto
both pulmonary arteries. A bilateral lower-extremity ven-
ous duplex scan was negative for acute deep venous
thrombosis. Lung scintigraphy showed no visualization of
the right lung on a technetium-99 m (99mTc-MAA) per-
fusion scan, but a ventilation scan showed no evidence of
a ventilation defect, which was consistent with ventilation
perfusion mismatch.
For the differentiation of the pulmonary artery mass be-
tween the thrombus and neoplasm, 18F-fluorodeoxyglucose
uptake in positron emission computed tomography (FDG-
PET) was performed to confirm the neoplastic features
and the distant metastatic extent of the disease. The results
of the FDG-PET showed a large mass, but no definite up-
take in the mass, and no other hypermetabolic lesions were
noted elsewhere (Figure 2). Our presumptive diagnosis
was a massive mural thrombus and concomitant chronicFigure 2 Maximum intensity projection image of 18fluorodeoxyglucos
uptake of FDG in a chest image (left). An axial section shows large intraluthromboembolic disease. Intravenous heparin and recom-
binant human tissue-type plasminogen activator were sub-
sequently administered.
After one day, the clinical presentation of the patient
with progressive dyspnea and signs of congestive heart
failure led us to decide on an emergent surgical ap-
proach. The patient was placed under general anesthesia.
A standard median sternotomy and cardiopulmonary
bypass was performed with aortic arterial and bicaval
venous cannulation. After the aorta was clamped, cold
blood cardioplegia was infused. The outer surface of the
pulmonary arteries revealed no pathologic features, and
longitudinal pulmonary arteriotomy was performed. In
the lumen of the main pulmonary artery, a multi-
lobulated whitish-yellow mass (Figure 3) was seen, and
most of it involved the vascular inner wall. The main
pulmonary artery was almost completely occluded by
the mass and the mass had partially adhered to the pul-
monic valve annulus. The small polypoid mass presented
on the right ventricular outflow tract, and the main mass
extended distally to both main pulmonary arteries. The
main mass was resected along with part of the pulmon-
ary artery wall but the pulmonary valve annulus was
treated by curettage only and the leaflets were preserved.e positron emission tomography (FDG-PET) shows no specific
minal masses in the pulmonary artery without significant FDG-uptake.
Figure 3 The large multiple lobulated mass is seen through the main pulmonary artery (arrow). The mass extended distally to both
pulmonary artery branches with a retrograde extension to the pulmonary valve and right ventricular outflow tract (left). Resected tumor masses
(right). RV: right ventricle, MPA: main pulmonary artery.
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was resected through the pulmonary valve. The
remaining masses on both branched pulmonary arteries
were also resected. The defect in the pulmonary artery
was repaired with a bovine pericardium patch. Even
though as much as possible of both distal pulmonary
artery masses were removed, there was no backflow
from the right pulmonary artery and scanty backflow
from the left pulmonary artery.
The intraoperative frozen biopsy was suggestive of sar-
coma. We tried weaning the patient from cardiopulmo-
nary bypass, but had to use extracorporeal membrane
oxygenation (ECMO) due to the unstable vital status.
Permanent histological findings revealed a non-
distinctive myxoid spindle cell sarcoma with a rather
lobulated, exophytic growth pattern. Some mitotic activ-
ity was seen and pleomorphic tumor cells surrounded
the endothelium, in particular (Figure 4). It was also
highly malignant, but its cellularity was decreased with
marked interstitial myxoid tissue. Immunostains showed
multifocal positivity for smooth muscle actin, as well as
focal positivity for desmin, consistent with myofibrob-
lastic differentiation, while CD34 and S-100 protein were
negative.Figure 4 Histological examination revealed atypical spindle cells with
cellularity with marked myxoid tissue. (hematoxylin-eosin stain; original
positivity for smooth muscle actin as well as focal positivity for desmin con
(right). These findings are consistent with intimal sarcoma.Given the poor prognosis and inability to wean the pa-
tient from the ECMO, we decided to withdraw the life
support system after 5 days.
Discussions
The clinical features of pulmonary intimal sarcoma are
similar, and it is frequently misdiagnosed as chronic pul-
monary thromboembolism. It may include right heart
failure due to pulmonary hypertension, along with such
as a cough, dyspnea, chest pain, hemoptysis, and syn-
cope. However, if concomitant symptoms include fever,
cachexia, and anemia but no risk factors for venous
thrombosis, malignancy should be considered. In our
case, our initial diagnosis was pulmonary thrombo-
embolism due to laboratory tests and radiologic features.
There was no hematologic evidence of intrinsic hyper-
coagulability, but D-dimer was 0.816 ug/ml (normal
range: 0–0.5).
Advances in imaging technology, such as echocardiog-
raphy, contrast-enhanced computed tomography, and
magnetic resonance imaging, have supported better diag-
noses of masses in the pulmonary artery, but without
always differentiating successfully between a thrombus
and a malignancy. The FDG-PET is a more reliablehyperchromatic, pleomorphic nuclei and some mitoses but poor
magnification 100x) (left). Immunostains with CD34 show multifocal
sistent with myofibroblastic differentiation (original magnification 200x)
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and the distant metastatic extent of the disease, due to in-
creased FDG uptake in its malignancy. Even though, FDG
is not a tumor-specific agent, FDG-PET is increasingly
used. Several authors have reported that FDG-PET has
been useful in a diagnostic workup for differentiating
among or staging malignant diseases, and monitoring the
response to treatment of pulmonary artery intimal sar-
coma [4,5]. Among unusual findings, Mathias et. al. [6]
reported a pulmonary intimal sarcoma with a lack of up-
take of FDG in PET. It also revealed highly malignant
cells, but its cellularity was low with marked interstitial
myxoid tissue. Also in our patient, the FDG uptake was
not significant, and we decided that the mass was a
thrombus with distal embolic progression. Even though
the character of the tumor was highly malignant, if the
cellularity was low and myxoid tissue was marked, a nega-
tive FDG-PET study would have been possible. The
patient mass did not take up FDG significantly in the
FDG-PET, and thus we misdiagnosed it as a thrombus.
This mistaken diagnosis could have led to inappropriate
therapy, such as anticoagulation and thrombolysis. Unfor-
tunately, there were few treatment options and there are
no specific guidelines on the management of pulmonary
artery sarcomas. The usual therapy is a surgical approach
with adjuvant chemotherapy [7,8]. The prognosis, which
depends on the location and vascular extension, is very
poor without surgery. The surgical procedures, such as
pneumonectomy, palliative stenting, and endarterectomy
of the pulmonary artery, depend on the tumor site. Even if
patients present with unresectable lesions, debulking sur-
gery might still be needed for hemodynamic improvement.
Some cases that have undergone surgery have had a long-
term survival of approximately 3 years for isolated local
tumors [9]. However, in our patient, both distal pulmonary
arteries were completely or partially obstructed with the
thrombi. Thus, complete removal of the tumor embolus
was impossible, postoperative hemodynamic status was
very poor, and ECMO was needed.Conclusion
Intimal sarcoma of the pulmonary artery is a rare malig-
nant tumor that may be misdiagnosed as pulmonary
thromboembolism, even if advanced imaging technology
is used. Even though the FDG is poorly taken up in PET,
the possibility of malignancy should be considered. We
report a case of pulmonary artery intimal sarcoma that
was not initially diagnosed as a malignancy due to poor
uptake of FDG in a PET study.Consent
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